溶解性:10mg/mL in Water 活性:≥ 150µ/mg 外观(性状):白色或类白色粉末 储存条件:RT 单位:瓶 有效期:2 年 应用: 抗凝血药,可阻抑血液的凝结过程,用于防止血栓形成;在生化研究中,主要用于防 止血液样本凝固。 使用方法: 用水配置,溶液配好后过滤除菌,可于 4℃保存两年 具体用量依不同实验而异。
thromboembolic (te) prophylaxis using low-dose unfractionated heparin (ld-ufh), ie, 5000 iu given subcutaneously twice or 3 times daily is effective, has low bleeding risk, and is generally not expected to prolong partial thromboplastin times (ptts). laboratory monitoring or dose adjustments based...
One kg of dried pig skin was suspended in 5 l of 0.5 M of NaCl, 0.01 M EDTA and 0.01 M of cysteine hydrochloride, pH 6.5. 500 mg of crystalline papain was added and the digestion was allowed to proceed for 50 h. The digest was filtered and then precipitated with 75 ml of a 10%...
Pulmonary embolism remains a major cause of death in high-risk medical and surgical patients. This is unfor tunate as effective measures for prevention of ... RD Hull,GF Pineo - 《Clinical & Applied Thrombosis/hemostasis》 被引量: 1发表: 2016年 Heparin-induzierte Thrombopenie (HIT) Goal...
Als nichtlimitierende Beispiele für brauchbare Wirkstoffe oder Wirkstoffgemische sind zu nennen: Clivarin, Arixtra sowie Heparinoide, die Di-, Tetra- und Hexasaccharidfragmenten umfassen. Ein erfindungsgemäß bereitgestelltes Medikament kann dabei ein oder mehrere Heparine oder Heparinderivate,...
Ichikawa, IekuniYoshida, YoshiyukiFogo, AgnesPurkerson, Mabel LKlahr, SauloElsevier BVKidney InternationalIchikawa I, Yoshida Y, Fogo A, Purkerson ML, Klahr S: Effect of heparin on the glomerular structure and function of remnant nephrons. Kidney Int 34: 638-644, 1988...
These LMWP fractions, particularly TDSP5, were effective and fully capable of neutralizing a broad spectrum of heparin-induced anticoagulant activities (ie, aPTT, anti-Xa, and anti-IIa activities). Additionally, these LMWP fractions could neutralize the activities of commercial LMWH. As assessed by ...